Molbio Diagnostics IPO Live Subscription Status
Real-time subscription data from BSE & NSE with category-wise breakdowns
📈 Building steadily
📈 GMP Today
🎟️ Allotment Status
📄 Full IPO Details
Listed at BSE & NSE · Registrar: Kfin Technologies Ltd.
Price: ₹768 - ₹807
Lot: 18
Min: ₹14,526
Period: 10 Aug - 12 Aug
Subscribed
70.24x
Total Demand
₹46,244 Cr
Applications
—
Subscription (Shares)
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIB | 23,25,145 | 43,33,82,148 | 186.39 |
| NII | 17,43,860 | 8,68,32,324 | 49.79 |
| bNII (>10 Lakh) | 11,62,574 | 5,90,76,594 | 50.82 |
| sNII (2-10 Lakh) | 5,81,286 | 2,77,55,730 | 47.75 |
| Retail | 40,69,005 | 5,25,53,898 | 12.92 |
| Employee Reserved | 20,519 | 2,71,674 | 13.24 |
| TOTAL | 81,58,529 | 57,30,40,044 | 70.24 |
Application Breakup
| Category | Reserved | Applications | Times |
|---|---|---|---|
| NII | 6,920 | 3,44,573 | 49.79 |
| bNII (>10 Lakh) | 4,613 | 47,566 | 10.31 |
| sNII (2-10 Lakh) | 2,307 | 1,10,142 | 47.74 |
| Retail | 2,26,056 | 29,19,661 | 12.92 |
| Employee Reserved | 1,140 | 15,093 | 13.24 |
| TOTAL | 2,41,036 | 34,37,035 | 14.26 |
Subscription (Crores)
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIB | 187.64 | 34,973.94 | 186.39 |
| NII | 140.73 | 7,007.37 | 49.79 |
| bNII (>10 Lakh) | 93.82 | 4,767.48 | 50.82 |
| sNII (2-10 Lakh) | 46.91 | 2,239.89 | 47.75 |
| Retail | 328.37 | 4,241.10 | 12.92 |
| Employee Reserved | 1.66 | 21.92 | 13.24 |
| TOTAL | 658.39 | 46,244.33 | 70.24 |
Subscription by Category
1× = fully subscribed · capped 10×
Estimated Allotment Chance
Retail
8.8%
(12.92x subscribed)
Low chance
S-HNI (2-10L)
2.1%
(47.75x subscribed)
Low chance
B-HNI (>10L)
9.7%
(50.82x subscribed)
Low chance
Employee
7.6%
(13.24x subscribed)
Low chance
If 100 retail investors apply, approximately 9 will get allotment.
Estimated from current subscription data, calibrated against published basis-of-allotment results.
Actual allotment depends on the number of applications received and SEBI's allotment rules —
draw of lots for Retail, Employee and NII; proportionate for QIB.
Disclaimer: Subscription data is sourced from BSE and NSE.
Please verify with official exchange websites before making any investment decisions.
This information is for educational purposes only and should not be construed as investment advice.
Molbio Diagnostics IPO Subscription — Detailed Analysis
Where Molbio Diagnostics Subscription Stands Today
Molbio Diagnostics IPO has been subscribed 70.24 times overall — a heavily oversubscribed level that signals strong investor demand and improves the prospects of a positive listing day.
Molbio Diagnostics IPO Subscription — FAQs
Molbio Diagnostics IPO is currently subscribed 70.24 times overall.
Molbio Diagnostics IPO is open for subscription from August 10, 2026 to August 12, 2026.
The price band for Molbio Diagnostics IPO is ₹768 - ₹807 per share.
New to subscription data? The hub explains what QIB, NII and Retail mean and how to read the table. For allotment odds from these numbers, see the allotment chances calculator or our IPO allotment process explainer.
Explore More
Quick links to all IPO sections
Open IPO
Live now
Best IPO Today
Top picks
Upcoming IPO
Coming soon
IPO Calendar
Dates & schedule
Closed IPO
Allotment pending
Listed IPO
Listing gains
IPO GMP
Grey market premium
Subscription
Live bidding data
Allotment
Check status
SME IPO
Small & medium
Mainboard IPO
Large cap
Performance
Listing returns
Learn
IPO guides